Valerenic acid potentiates and inhibits GABAA receptors: Molecular mechanism and subunit specificity
- 31 July 2007
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 53 (1), 178-187
- https://doi.org/10.1016/j.neuropharm.2007.04.018
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Automated fast perfusion of Xenopus oocytes for drug screeningPflügers Archiv - European Journal of Physiology, 2006
- Pharmacokinetics of valerenic acid after administration of valerian in healthy subjectsPhytotherapy Research, 2005
- Novel Plant Substances Acting as β Subunit Isoform-Selective Positive Allosteric Modulators of GABAAReceptorsMolecular Pharmacology, 2005
- The relative amount of cRNA coding for γ2 subunits affects stimulation by benzodiazepines in GABAA receptors expressed in Xenopus oocytesNeuropharmacology, 2002
- Activation and block of recombinant GABAA receptors by pentobarbitone: a single‐channel studyBritish Journal of Pharmacology, 2000
- The benzodiazepine binding site of GABAA receptorsTrends in Pharmacological Sciences, 1997
- Direct Activation of GABAA Receptors by Loreclezole, an Anticonvulsant Drug with Selectivity for the β-SubunitNeuropharmacology, 1996
- Desensitized states prolong GABAA channel responses to brief agonist pulsesNeuron, 1995
- A novel allosteric modulatory site on the GABAA receptor β subunitNeuron, 1994
- Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extensionGene, 1989